A decrease in the activated Notch1 and PTEN protein levels can predict prognoses and chemotherapeutic resistance.GEM can induce the upregulation of Notch1 in pancreatic cancer cells and increase the expression of the Notch intracellular domain (NICD) (47). The gene discussed is PTEN; the disease is familial pancreatic carcinoma.